ABSTRACT
potentially avoidable event. This secondary neuronal death is determined by a large number of cellular, molecular, and biochemical cascades. One such cascade thought to contribute to the evolution of this secondary damage is the local inflammatory response in the injured brain tissue. [2] Microglial cells have been suggested to be the source of cytotoxic cytokines, such as tumor necrosis factor alpha (TNF-α) and interleukin 1β (IL-1β), killing oligodendrocytes. In fact, increased synthesis and/or secretion of IL-1β is detectable at the injury site within one h after spinal cord injury (SCI). IL-1β is a member of the interleukin 1 cytokine family. The gene encoding IL-1β, along with eight other IL-1 family genes, form a cytokine cluster on chromosome 2. [3] IL-1β is produced by activated macrophages as a pro-protein, which is proteolytically processed to its active form by caspase 1 (CASP1/ICE). This cytokine is an important mediator of the inflammatory response and involves in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis. [3] 
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INTRODUCTION
Traumatic brain injury (TBI) immediately causes direct mechanical damage to the brain, referred to as the primary damage, [1] resulting in the immediate death of a number of neurons that cannot be recovered or regenerated. However, neurons continue to die for hours after TBI, representing a IL-1 is produced in response to inflammatory stimuli and mediates various physiologic responses, including inflammatory and immunologic reactions. Anakinra, an antagonist expressed in many tissues and organs, has been shown to competitively inhibit the binding of IL-1 to the IL-1 type receptor. [4] In patients with rheumatoid arthritis, this natural IL-1 receptor antagonist is not found in effective concentrations to counteract elevated IL-1 concentrations. Thus, Kineret is not considered a disease-modifying anti-rheumatic drug, but rather a biological response modifier due to its ability to selectively target the pathologic element of the disease. [5] In the current study, the following endpoints of the inflammatory response were determined: histological damage; cytokine expression (IL-1β); measurement of lipid peroxidation and oxidative stress (glutathione peroxidase, malondialdehyde, and superoxide dismutase) and these various factors were used to evaluate whether Anakinra administration could protect brain tissue following traumatic brain injury.
MATERIALS AND METHODS
Fifty-four adult male Wistar albino rats weighing 300-350 g were used in this study. Animal care and all experiments were in accordance with the European Communities Council Directive of November 24, 1986 (86/609/EEC) on the protection of animals for experimental use. All experimental procedures used in this research were approved by the ethical committee of the Ministry of Health, Ankara Education and Research Hospital.
Surgical Procedure and Sample Preparation
All rats were kept under environmentally controlled conditions at 22-25°C with appropriate humidity, a 12-h light cycle, and free access to food and water. The surgical procedure was performed under general anesthesia induced by intraperitoneal (IP) xylazine (10 mg/kg; Bayer, Istanbul, Turkey) and Ketamine hydrochloride (50 mg/kg; Parke-Davis, Istanbul, Turkey). A rectal probe was inserted and the animals were positioned on a heating pad in order to ensure that their body temperature was maintained at 37°C. A moderate brain-injury model, described by Marmarou et al. and modified by Ucar et al., was applied for head trauma. [6, 7] Briefly, rats were placed in prone position and a midline incision was made on the head to expose the coronal and lambdoid sutures. A metallic disc in 10 mm diameter and 3 mm thickness was fixed to the cranium using bone wax, and a lead object weighing 450 g was allowed a free fall from a height of 70 cm through a copper tube onto the metal disc. The head of the animals was supported on a 10-cm foam bed providing confirmation of impact. After surgery, 1.0 cc of saline was subcutaneously administered to replace the blood volume lost during surgery and the wound was closed in layers with silk sutures. All animals were anesthetized with the above-mentioned agents at 24 h after trauma and their brains were extracted without any damage. Neural tissue samples were obtained by excising the left frontoparietal lobes from the boundary of the interhemispheric fissure and were subjected to biochemical analyses. The remaining parts of the brains were maintained in formaldehyde solution for histopathological analysis.
Experimental Groups
Rats were randomly allocated into the following 3 main groups and subgroups: Control: (n=18, 6 rats per time window); rats underwent skin incisions only and non-traumatic brain samples were obtained at the first, sixth and twenty-fourth h after surgery.
TBI + Saline: (n=18, 6 rats per time window); rats were subjected to TBI and received a single IP dose of 1 mL/kg saline. Traumatic brain tissue samples were obtained at the first, sixth and twenty-fourth h after surgery.
TBI + Anakinra: (n=18, 6 rats per time window); rats were subjected to TBI and received a single IP dose of Kineret (Anakinra, Swedish Orphan Biovitrum AB, Stockholm, Sweden) immediately following TBI. Traumatic brain tissue samples were then obtained at the first, sixth and twenty-fourth h after surgery.
Cytokine Assay
Serum and tissue IL-1β concentrations were determined using the double-antibody sandwich enzyme-linked immunosorbent assay (R & D systems, Minneapolis, MN, USA) according to the manufacturer's instructions.
Measurement of Lipid Peroxidation and Oxidative Stress Glutathione Peroxidase Analysis
Glutathione peroxidase (GSH-Px) activity was measured following changes in NADPH absorbance at 340 nm. [8] In the activity calculations (IU, international unit), extinction coefficients of NADPH were used for GSH-Px. Results were expressed as IU/mg protein.
Malondialdehyde Analysis
Malondialdehyde (MDA) is formed from the breakdown of polyunsaturated fatty acids and serves as an important and reliable index for determining the extent of peroxidation reactions. [9] Tissue MDA levels were determined by a method based on a reaction with thiobarbituric acid (TBA). Briefly, samples were mixed with two volumes of cold saline solution containing 0.001% butylated hydroxytoluene (BHT) (200 μl of 0.01% BHT solution in methanol) and 0.07% sodium dodecyl sulfate (SDS) (20 μl of 7% SDS). One ml of sample was then added to 500 μl of 0.01 NH2SO4 and 500 μl of the TBA reagent (0.67% TBA in 50% acetic acid) to precipitate protein. Samples were heated in boiling water for 60 min, and after cooling, an equal volume (2 ml) of n-butanol was added to each test tube and mixed. The mixture was centrifuged at 4,000 rpm for 10 min at room temperature. The absorbance of the organic layer in a 1-ml cell was read at 535 nm (Molecular Devices Corporation, Sunnyvale, CA, USA). MDA concentrations were expressed as nanomoles per milligram wet tissue weight.
Superoxide Dismutase Analysis
Total superoxide dismutase (SOD) (Cu-Zn and Mn, EC 1.15.1.1) activity was determined according to the method of Sun et al. [10] The principle of the method is based on the inhibition of nitroblue tetrazolium (NBT) reduction by the xanthine-xanthine oxidase system as a superoxide generator. Activity was assessed in the ethanol phase of the supernatant after 1.0 ml ethanol/chloroform mixture (5/3, v/v) was added to the same volume of sample and centrifuged. One unit of SOD was defined as the enzyme amount causing 50% inhibition in the NBT reduction rate. SOD activity was expressed as U/mg protein.
Catalase Analysis
Catalase (CAT) activity was determined by the method described by Aebi.
[11] The principle of CAT activity is based on the determination of the rate constant (k, sec-1) or of the hydrogen peroxide decomposition rate at 240 nm. Results were expressed as kU/g of protein.
Histopathological Procedures
For histological examination, brain tissue samples were fixed at 10% neutral buffered formalin, dehydrated through a graded series of ethanol and embedded in paraffin. 5μm thick sections stained with hematoxylin-eosin were analyzed and photographed with light microscopy (Olympus CX21, Olympus America Inc., Melville, NY, USA). In all groups, a semi quantitative scoring system, ranging between 0 and 3, was used for grading both histopathological changes (vascular congestion, PMNL infiltration, gliosis/satellitosis and spongiosis) and neuronal degeneration signs (cytoplasmic eosinophilia and nuclear pyknosis) in the brain tissues of each animal. Histopathological changes were evaluated by two observers blinded to the groups and scored as follows: 0: absent; 1: mild; 2: moderate; 3: common. Histopathological scores for each group was calculated averaging the scores of each animal in groups. [12] Statistical Analysis Data were analyzed using the Statistical Package for Social Sciences (SPSS) software version 19.0 for Windows (SPSS Inc., Chicago, IL). Non-parametric tests were applied and the Mann-Whitney U test was used to compare two independent groups while the Kruskal-Wallis test was used to compare more than two groups. The Wilcoxon Signed Ranks Test was used to compare two dependent groups while the Friedman Test was used to compare more than two groups. Bonferroni correction for multiple tests was used for post-hoc comparisons. All differences associated with a chance probability of 0.05 or less were considered statistically significant. Continuous variables were presented as mean±SD.
RESULTS
Tissue and Serum IL-1β Analysis Table 1 summarizes the changes in tissue and serum levels of IL-1β. Mean tissue and serum level of IL-1β were the same although tissue and serum samples were obtained at different time periods. There were statistically significant differences between the trauma (177.24±6.24 pg/ml), control (213.17±36.57 pg/ml), and Anakinra (94.8 4±24.45 pg/ ml) groups at the first h after trauma with regard to mean tissue IL-1β activity (p=0.001). After the sixth h, increased tissue IL-1β activity in trauma-and Anakinra-treated groups was shown at 180.86±5.89 pg/ml and 137.90±65.02 pg/ml, respectively. There was also a statistically significant difference determined between the groups (p=0.001). Trauma (214.78±45.06 pg/ml), control (213.17±36.57 pg/ml), and Anakinra (201.42±39.32 pg/ml) groups were compared at the twenty-fourth h after trauma with regard to mean tissue IL-1β activity and no statistically significant difference was found (p=0.149), even though tissue levels of IL-1β in Anakinra-treated groups continued to decline. There were, sixth h following TBI, respectively. A statistically significant difference was observed in mean serum GPx levels when the trauma and Anakinra groups were compared to the control group (0.0032±0.0013 IU/mg) at all time-points (p=0.003). However, there was no statistically significant difference in serum GPx levels between the three time-points of the Anakinra-treated groups (p=0.513) ( Table 2 ).
Tissue and Serum Superoxide Dismutase Analysis
Mean tissue SOD levels in the trauma groups were 10.05±0.52 U/mg, 17.82±7.11 U/mg, and 19.92 ± 4.25 nmol/mg at the first, sixth, and twenty-fourth h, respectively. The mean tissue SOD levels in the Anakinra group were 7.63±1.84 U/mg, 10.14±4.00 U/mg, and 13.46±1.46 U/mg at the first, sixth, and twenty-fourth h after trauma, respectively. Mean tissue SOD levels of the trauma and Anakinra groups were then compared with those of the control group (14.51±2.74 U/ mg) and a statistically significant difference was found at all time-points (p=0.003). Mean serum SOD levels in the control group were 0.08±0.02 U/mg and 0.08±0.01 U/mg at the first and sixth h after sham surgery, respectively. Mean serum SOD levels in the Anakinra group were 0.05±0.03 U/mg and 0.06±0.03 U/mg at the first and sixth h after trauma, respectively. When mean tissue SOD levels in trauma and Anakinra groups were compared with the control group (0.06±0.01 U/mg), no statistically significant differences were found between groups at any of the time-points (p=0.805) ( Table 2 ).
Tissue and Serum Catalase Analysis
Mean tissue CAT levels in the trauma group were 4.67±1.69 IU/mg, 4.06±0.47 IU/mg, and 7.11±1.85 IU/mg at the first, sixth, and twenty-fourth h, respectively. Mean tissue CAT levels in the Anakinra group were 10.63±3.55 IU/mg, 4.83±1.07 IU/mg, and 1.95±0.11 IU/mg 1, 6, and 24 h after trauma, respectively. When mean tissue CAT levels in the trauma and Anakinra groups were compared with the control group (3.48±0.91 IU/mg), a statistically significant difference was found between groups at all time-points (p=0.004). Mean serum CAT levels in the trauma group were 0.52±0.12 IU/ mg and 0.16±0.07 IU/mg at the first and sixth h, respectively. Mean serum CAT levels in the Anakinra group were 0.30±0.09 IU/mg and 0.30±0.26 IU/mg at the first and sixth h after trauma, respectively. No statistically significant difference was observed when CAT levels in the Anakinra group were com- pared to serum levels in the control group (0.28±0.06 IU/mg) at any of the time-points (p=0.56) ( Table 2 ).
Histopathological Assessment
All rats of the control group showed no nerve tissue damage in the brain cortex. Neurons and neuroglia cells had normal morphologic features (Fig. 1a) . In the first, sixth and twentyfourth h trauma groups, cortical neurons showed cytoplasmic eosinophilia so called eosinophilic neuron and pyknotic nucleus with no discernible nucleolus. Perineural satellitosis accumulating of more than one glia cell around eosinophilic neurons were also observed. The perineural and perivascular spaces were prominent due to the swelling of astrocytic foot processes. In addition, blood vessels showed congestion and stasis. The fibrillary matrix of the cerebral cortex (neurophil) showed spongiosis due to the edema of cellular extensions of the neurons and glia cells (Fig. 1b-d ). In the Anakinra applied groups, first, sixth and twenty-fourth h after trauma also showed same signs of damage of nerve tissue including neurons and neurophil of the brain cortex (Figs. 2a-f ). Neuronal degeneration (eosinophilic neurons with pyknotic nucleus) and satellitosis scores of the Anakinra groups were found to be better than trauma groups at the sixth and twenty-fourth h. Moreover, vascular congestion scores were determined to be lower than the trauma groups at all time points and PMNL infiltration was not seen in trauma and Anakinra groups at all time points (Table 3) .
DISCUSSION
Neuronal damage is thought to continue for several days after the initial ischemia expansion occurring within the first 24 h of TBI. [13] The expression of proinflammatory cytokines at the site of injury, including IL-1β and TNF-α, regulate precise cellular events that occur within the first few hours of TBI and persist in the neural tissue for several days with cytokines also being detectable on microglia, perivascular macrophages, and astrocytes. [14, 15] Most important secondary factors leading to further neuronal death are lipid peroxidation, apoptosis, and development of reactive oxygen species. [16] [17] [18] [19] [20] In our study, cellular and biochemical changes were observed in order to assess the actual outcome of TBI in relation to short-term histological damage and cytokine expression. Fassbender et al. have analyzed trauma-induced release of IL-1β in brain tissue perfusates and reported that IL-1β was unexpectedly detected within 60 min of injury. Moreover, extracellularly secreted IL-1β protein was found to gradually increase, peaking at day two, and decrease thereafter. Therefore, IL-1β release may represent a precondition for the orchestrating role of this mediator in the inflammatory response cascade. [21] In this study, we also demonstrated that serum and tissue levels of IL-1β were elevated at the sixth h after TBI. As shown in our results, Anakinra was found to be more effective in reducing tissue levels of IL-1β in the first h after trauma. This finding is not surprising since the release of IL-1β in brain tissue occurs within less than one h of trauma. Rothwell et al. have shown that neuronal inflammation, inducing pro-cytokine IL-1β, plays a key role in this process involving glial cells as well as invading immune cells. Moreover, induced cytokines have been suggested to indicate the extent of central nervous system injury. [14, 22] In the present study, morphological features relevant with neuronal injury and higher histopathological scores following brain trauma in rats were demonstrated. In contrast, administration of Anakinra led to an improvement of nerve tissue and cell morphology after TBI through a reduction in oxidative stress. Furthermore, this amelioration was revealed to be associated with decreased tissue and serum levels of IL-1β. On the contrary, no significant reduction in MDA was observed, indicating a lack of lipid peroxidation inhibition in brain sections and serum levels obtained from Anakinratreated rats. This observation is in disagreement with a study conducted by Marini et al. demonstrating that inhibition of lipid peroxidation has reduced IL-1β expression and protected neuronal tissue from damage. [20] Finally, the evaluation with light microscopy showed that the histopathological damage scores of neuronal degeneration, satellitosis, vascular congestion and spongiosis were reduced in rats treated with Anakinra at the twenty-fourth h after TBI. The findings of the current study suggested that IL-1β played a detrimental role in the development and severity of post-traumatic injury and that this damaging effect could be attenuated by blocking this cytokine's signaling pathway.
Treatment with Anakinra inhibits IL-1β and protects the brain tissue and neuronal cells from damage in TBI. However, a few of the possible mechanisms by which Anakinra attenuates neurological injury were demonstrated in this study and a better understanding of the mechanisms of Anakinra might lead to future clinical strategies aimed at treating TBI.
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